Usually the first step is conservative treatment. Patients who have radicular symptoms but who do not have weakness or myelopathy can be treated conservatively. Conservative treatment can include ...

Karin Wuertz-Kozak described her lab test equipment as a gym for cells. Stretching and compressions tests using bioreactors—her lab equipment—can make a difference in understanding how cells respond ...

Did you know that chronic lower back pain is the single greatest cause of years lived with disability worldwide? One of the main causes of lower back pain is lumbar degenerative disc disease. This is ...

Did you know that chronic lower back pain is the single greatest cause of years lived with disability worldwide? One of the main causes of lower back pain is lumbar degenerative disc disease. This is ...

A recent study has unveiled the pivotal role of Ferroptosis Suppressor Protein 1 (FSP1) in intervertebral disc degeneration (IDD), a primary cause of chronic lower back pain. Researchers discovered ...

Therapies that target aging cells early pave the way to easing back pain. "Once intervertebral discs start to degenerate, there is very little regeneration that happens," says Dr. Risbud. "But our ...

Phase I/II data of IDCT (rebonuputemcel), a cell therapy in development for chronic and progressive lumbar degenerative disc disease and one that has both regenerative medicine advanced therapy and ...

A new research paper was published in Volume 17, Issue 9 of Aging-US on September 8, 2025, titled, "Runx1 overexpression induces early onset of intervertebral disc degeneration." In this study, led by ...

Please provide your email address to receive an email when new articles are posted on . High-dose injectable disc cell therapy may yield improved outcomes for patients with degenerative disc disease.